Cross-reactivity between peptide mimics of the immunodominant myelin proteolipid protein epitope PLP139-151: comparison of peptide priming in CFA vs. viral delivery

J Neuroimmunol. 2007 May;186(1-2):5-18. doi: 10.1016/j.jneuroim.2007.02.002. Epub 2007 Mar 21.

Abstract

Epidemiological evidence suggests that pathogens may trigger the development of autoimmune diseases such as multiple sclerosis (MS). Pathogens may trigger disease via molecular mimicry, wherein T cells generated against foreign epitopes are also cross-reactive with self-epitopes. Five pathogen-derived molecular mimics of PLP(139-151) (the immunodominant CD4(+) T cell myelin epitope in SJL mice) were previously identified. This study examines the degree of cross-reactivity between the different mimics, comparing mice primed with mimic peptide in CFA with mice infected with recombinant mimic-expressing viruses. The pattern of in vitro reactivity and ability to induce CNS disease differs between peptide priming and virus infection.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • Cells, Cultured
  • Cross Reactions
  • Demyelinating Autoimmune Diseases, CNS / immunology*
  • Demyelinating Autoimmune Diseases, CNS / virology*
  • Disease Models, Animal
  • Dose-Response Relationship, Immunologic
  • Female
  • Freund's Adjuvant / immunology
  • Immunodominant Epitopes / genetics
  • Immunodominant Epitopes / immunology*
  • Mice
  • Molecular Mimicry / immunology*
  • Myelin Proteolipid Protein / genetics
  • Myelin Proteolipid Protein / immunology*
  • Peptide Fragments / genetics
  • Peptide Fragments / immunology*
  • Time Factors
  • Viruses / immunology

Substances

  • Immunodominant Epitopes
  • Myelin Proteolipid Protein
  • Peptide Fragments
  • myelin proteolipid protein (139-151)
  • Freund's Adjuvant